tradingkey.logo
tradingkey.logo
Search

Privia Health Group Inc

PRVA
Add to Watchlist
23.670USD
+0.260+1.11%
Close 06/18, 16:00ETQuotes delayed by 15 min
2.91BMarket Cap
133.51P/E TTM

Earnings Forecast

Currency: USD Updated: 2026-06-18
Previous score
8.48
Change
-0.08
The current earnings forecast score of Privia Health Group Inc is 8.40, ranking 17 out of 76 in the Healthcare Providers & Services industry. The average price target is 31.00, with a high of 37.00 and a low of 23.00.

Analyst Rating

Based on 20 analysts
Buy
Current Rating
31.235
Target Price
+31.96%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

68
Total
8
Median
9
Average
Company name
Ratings
Analysts
Privia Health Group Inc
PRVA
20
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
27
HCA Healthcare Inc
HCA
26
Natera Inc
NTRA
23
Tenet Healthcare Corp
THC
23
1
2
3
...
14

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

FAQs

What is Privia Health Group Inc's expected revenue for the next quarter?

Privia Health Group Inc's expected revenue is 598.10M.

What is Privia Health Group Inc's price target?

Analysts forecast that Privia Health Group Inc's price target is USD 31.00, with the highest forecast at USD 37.00 and the lowest forecast at USD 23.00.

How have Privia Health Group IncPRVA's recent earnings per share performed?

The market expectation was USD 0.02, while Privia Health Group IncPRVA's earnings per share (EPS) for the previous quarter was USD 0.07. EPS for the next quarter is expected at USD 0.07.

What is the analyst rating for Privia Health Group Inc?

Based on the ratings of Privia Health Group Inc's stock from 20 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
KeyAI